Patient
SITE005-0090
enrolled Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE005 (FRA) (Dr. Muller)
consented 2025-12-21
Adverse events
2
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 2
mild
assessed
2026-07-30
Grade 1 Fatigue — outcome: RECOVERED/RESOLVED; onset 2023-01-23 (study day 211); relationship: RELATED
moderate
assessed
2026-02-03
Grade 2 Thrombocytopenia — outcome: RECOVERED/RESOLVED; onset 2022-07-30 (study day 34); relationship: not assessed
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.